business
MoonLake Immunotherapeutics (MLTX) Price Target Raised to $45 At H.C. Wainwright on FDA Progress
MoonLake Immunotherapeutics (MLTX) Price Target Raised to $45 At H.C. Wainwright on FDA Progress
Read full story on Yahoo Finance → More top storiesAlso covered by
Investing.com
Stifel raises MaxLinear stock price target to $105 on AI momentum
Investing.com
BofA raises Crocs stock price target on DTC momentum to $145
Investing.com
Mizuho raises STMicroelectronics stock price target on AI growth
Investing.com
Mizuho lowers Medtronic stock price target to $100 on valuation
Aggregated and edited by the Scoop newsroom. We surface news from Yahoo Finance alongside other reporting so you can compare coverage in one place.
Editorial policy · Corrections · About Scoop